demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID 19 all comersCOVID-19 mild to moderate
COVID 19 hospitalizedCOVID 19 all comersCOVID-19 mild to moderate
Renin-angiotensin-system-acting agents
angiotensin receptor blockers (ARBs) Nouri-Vaskeh Duarte
losartan University of Minnesota
discontinuation of ACEI/ARB Najmeddin REPLACE Lopes ...

9 studies excluded by filtering options 1

5092 Yang, 2020 1133not a RCThigh risk of bias
5228 Bean, 2020 1193not a RCThigh risk of bias
5295 Zhang, 2020 1133not a RCThigh risk of bias
5331 Li, 2020 1134not a RCThigh risk of bias
5332 Meng, 2020 1134not a RCThigh risk of bias
5345 Yan et al., 2020 1204not a RCThigh risk of bias
5347 Mehra, 2020 2124excludednot a RCThigh risk of bias
6139 Dublin, 2020 0120selection pending
6139 Dublin, 2020 0120selection pending